UBS Group
IXHL icon

UBS Group’s Incannex Healthcare IXHL Stock Holding History

UBS Group’s Portfolio IXHL Stock Details IXHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6K Sell
3,610
-36,759
-91% -$134K ﹤0.01% 8383
2026
Q1 		$121K Buy
40,369
+35,544
+737% +$258K ﹤0.01% 6910
2025
Q4 		$51.8K Sell
4,825
-816
-14% -$9.42K ﹤0.01% 7198
2025
Q3 		$78.5K Buy
5,641
+3,265
+137% +$53K ﹤0.01% 7271
2025
Q2 		$15.4K Buy
2,376
+2,146
+933% +$21.2K ﹤0.01% 8613
2025
Q1 		$4.66K Sell
230
-79
-26% -$3.43K ﹤0.01% 9080
2024
Q4 		$19.6K Buy
309
+211
+215% +$12.7K ﹤0.01% 7884
2024
Q3 		$5.84K Sell
98
-102
-51% -$6.3K ﹤0.01% 8021
2024
Q2 		$17.6K Buy
200
+103
+106% +$8.89K ﹤0.01% 7384
2024
Q1 		$10.5K Buy
+97
New +$11.7K ﹤0.01% 7227
2023
Q4 		– Sell
-1
Closed -$90 – 9592
2023
Q3 		$90 Buy
+1
New +$192 ﹤0.01% 8910
2023
Q1 		– Sell
-25
Closed -$8.43K – 9967
2022
Q4 		$8.43K Sell
25
-3
-11% -$1.37K ﹤0.01% 8772
2022
Q3 		$15K Buy
28
+19
+211% +$9.95K ﹤0.01% 7804
2022
Q2 		$4K Sell
9
-14
-61% -$11.4K ﹤0.01% 9080
2022
Q1 		$25K Buy
+23
New +$38K ﹤0.01% 7192

Other funds holding IXHL

LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group's IXHL Position: Q2 2026 in Review

UBS Group reduced its Incannex Healthcare (IXHL) stake by 91% in Q2 2026, selling an estimated $134K and leaving 3,610 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #8383.

UBS Group first reported a position in IXHL in Q1 2022 and has held it in 15 quarters since. The position peaked at $121K in Q1 2026. 15 funds tracked by Wall St. Rank hold IXHL as of Q2 2026.

  • UBS Group held 3,610 shares of Incannex Healthcare worth $13.6K as of Q2 2026.
  • UBS Group sold 36,759 Incannex Healthcare shares in Q2 2026, an estimated $134K.
  • Incannex Healthcare made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8383 holding.
  • UBS Group first reported a position in Incannex Healthcare in Q1 2022 and has held it in 15 quarters since.
  • UBS Group's Incannex Healthcare position peaked at $121K in Q1 2026.
  • 15 funds tracked by Wall St. Rank held Incannex Healthcare as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.